RAND Corporation, Arlington, Virginia, USA.
RAND Corporation, Pittsburgh, Pennsylvania, USA.
J Palliat Med. 2022 Jun;25(6):864-872. doi: 10.1089/jpm.2021.0424. Epub 2021 Dec 21.
There is a pressing need for standardized measures to assess the quality of home-based serious illness care. Currently, there are no validated quality measures that are specific to home-based serious illness programs (SIPs) and the unique needs of their patients. : To develop and evaluate standardized survey-based measures of serious illness care experiences for assessing and comparing quality of home-based serious illness care programs. From October 2019 through January 2020, we administered a survey to patients who received care from 32 home-based SIPs across the United States. Using the 2263 survey responses, we assessed item performance and constructed composite measures via factor analysis, evaluated item-scale correlations, estimated reliability, and examined validity by regressing overall ratings and willingness to recommend care on each composite. The overall survey response rate was 36%. Confirmatory factor analyses supported five composite quality measures: Communication, Care Coordination, Help for Symptoms, Planning for Care, and Support for Family and Friends. Cronbach's alpha estimates for the composite measures ranged from 0.69 to 0.85, indicating adequate internal consistency in assessing their underlying constructs. Interprogram reliability ranged from 0.67 to 0.80 at 100 completed surveys per measure, meeting common standards for distinguishing between programs' performance. Together, the composites explained 45% of the variance in patients' overall care ratings. Communication, Care Coordination, and Planning for Care were the strongest predictors of overall ratings. Our analyses provide evidence of the feasibility, reliability, and validity of proposed survey-based measures to assess the quality of home-based serious illness care from the perspective of patients and their families.
目前,没有经过验证的专门针对家庭严重疾病计划(SIP)及其患者独特需求的质量衡量标准。因此,迫切需要标准化措施来评估家庭严重疾病护理的质量。本研究旨在开发和评估基于标准化调查的严重疾病护理体验衡量标准,用于评估和比较家庭严重疾病护理计划的质量。
2019 年 10 月至 2020 年 1 月,我们向美国 32 个家庭 SIP 接受护理的患者发放了一份调查。我们使用 2263 份调查回复,通过因子分析评估项目表现并构建综合衡量标准,评估项目-量表相关性,估计可靠性,并通过回归总体评分和对护理的推荐意愿来检验有效性。
总体调查回复率为 36%。验证性因子分析支持五个综合质量衡量标准:沟通、护理协调、症状帮助、护理计划和家庭和朋友支持。综合衡量标准的 Cronbach's alpha 估计值在 0.69 到 0.85 之间,表明在评估其潜在结构方面具有足够的内部一致性。每个衡量标准的 100 项完整调查的计划间可靠性范围为 0.67 到 0.80,符合区分计划表现的常见标准。综合衡量标准共同解释了患者总体护理评分的 45%。沟通、护理协调和护理计划是总体评分的最强预测因素。
我们的分析提供了基于调查的衡量标准来评估家庭严重疾病护理质量的可行性、可靠性和有效性的证据,这些衡量标准是从患者及其家属的角度提出的。